Shortness of BreathNCT06196957
Effect of Senobi Versus Buteyko Technique on Functional Performance of Chronic Obstructive Pulmonary Disease Patient.
A study testing pursed lip breathing in people with Shortness of Breath, run by Riphah International University at 1 site in Pakistan.
Trial summary
Effect of Senobi breathing exercise versus Buteyko breathing technique on functional performance among chronic obstructive pulmonary patient. Read more about this study
- Who is it for?
- Ages 40 to 80 years
- Conditions the study is for
- Shortness of Breath
- What is being tested?
- pursed lip breathing
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 32 participants
- Where
- 1 sitePakistan
- Study dates
- 20 Jul 2023to 10 Dec 2023
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 40 to 80 years
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Age 40 -80
- COPD patient in stage 2 (GOLD criteria)
- Dyspnea (FEV1< 70 %)(26)
- Maximum expiratory pressure: 50%
- Smoker
Who cannot join
- Patient with Tumor
- Patient with Cardiac Arrhythmias Patient
- Patient with cancer
- insulin dependent diabetes
- patient with thyroid disease
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Effect of Senobi Breathing Exercise Versus Buteyko Breathing Technique on the Functional Performance Among Chronic Obstructive Pulmonary Disease Patient.
Effect of Senobi breathing exercise versus Buteyko breathing technique on functional performance among chronic obstructive pulmonary patient.
Read the detailed description
chronic obstructive pulmonary disease is a chronic inflammatory lung disease that cause obstructed airflow from the lungs. Symptoms include Breathing difficulty. cough, mucus production and wheezing. Its typically caused by long term exposure to irritating gasses or particulate matter, most often from cigarette smoker.
Emphysema and chronic bronchitis are two most common condition that contribute to chronic obstructive pulmonary disease. Chronic obstructive pulmonary disease is progressive disease that gets over a time. Clinical trials will be Conducted in Gulab Devi chest hospital in Lahore. Through the convenient sampling Technique. Which will be allocated through the random sampling two groups are involved group A and group B. In group A check the effect of Senobi techniques (stretch the body) and in group B check the effect of Buteyko technique. (Inhale the through the nose while mouth is closed) by using 6 mint walk test, Borg scale and quality of life questionnaire. Apply the technique to check the effectiveness of dyspnea and quality of life of patient The Buteyko technique offers a complementary method of reliving respiratory symptoms based on the voluntary control of breathing as well as considering the effect of environmental and dietary trigger. Data will be collected by the questionnaire and analyzed by using statistical package for the social science SPSS software version 21. The Buteyko method made its way to Australia to Europe and the unite states in 1990, it become best for the asthma and chronic obstructive pulmonary disease patient. The Senobi stretch exercise of the respiratory muscle improve the chest expansion and also improve the chest wall mobility in chronic obstructive pulmonary disease patient. Senobi breathing exercise was found to be effective for depression and it regulate the sympathetic nerve activity.
- Conditions
- Shortness of Breath
- Being tested
- pursed lip breathing
- Keywords
- Dyspnea, Quality of life, senobi,and buteyko
- Medical subject headings
- Dyspnea
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
pursed lip breathingCombination product
Also called Senobi technique
pursed lip breathing
| Study group | Role | What they receive |
|---|---|---|
| Buteyko technique | Experimental | GROUP A'(Buteyko technique)
Participant in group A will be instructed to perform the Buteyko breathing exercise.
Patient either on the sitting position or standing position.
Patient will be relaxed the shoulder and rest lower back against the back of chair.
Close the mouth while only breathing through nose.
Breath into the diaphragm and chest should be still.
Exhale slowly, then hold the breath.
Use the index finger and thumb to plug the nose, Hold the breath until there is urge to breath Then inhale
Repeat several times. With in 15 minutes. Receives: Combination Product: pursed lip breathing |
| Senobi technique | Active comparator | GROUP B (Senobi techniques)
Senobi breathing exercise will be performed from standing, Arms will be extended firmly,
The neck was extended so as face the ceiling. And the patient instructed to avoid over exertion
Take a deep breath, hold for 3 second and then exhale through mouth.
The time of exercise will be 15 minutes. Receives: Combination Product: pursed lip breathing |
What is being measured
The primary outcome is the main question the study is designed to answer.
CASA Q (cough and sputum )
The cough and sputum assessment questionnaire (CASA-Q) was used to measure the severity and impact of cough and sputum in patients with COPD and chronic bronchitis. CASA-Q scores of each domain demonstrated significant association with HRQoL impairment CASA-Q was strongly lower when chronic bronchitis was present, but multivariate analyses demonstrated that the association of HRQoL impairment was greater with the cough impact domain score than with the usual definition of chronic bronchitis. The CASA-Q targets cough and sputum by an original approach assessing both the symptoms and impacts in dailyactivities within the last 7 days. Each item is answered ranging from never to always or from not at all to a lot / extremely as applicable each type is answered using five categories.
Measured: 4 weeks
Dyspnea rating scale.
This scale is used for the measurement of the dyspnea ( shortness of breath ).This scale is questionnaire that consist of 5 breathlessness grade ,and the number 5 have maximum dyspnea
Measured: 4 weeks
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted9 Jan 2024
- Study start20 Jul 2023
- Primary completion1 Dec 2023
- Study completion10 Dec 2023
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (3)Papers the sponsor has linked to this study.
- Other trials for Shortness of BreathStudies of the same condition, open and under way.
- More trials run by Riphah International UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind
- Who is masked
- Participant
- Enrolment
- 32 participants (actual)
Sponsor and investigators
- Lead sponsor
- Riphah International University
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
- Investigators
- Sumera abdulhameed, ms, Principal investigator, Riphah International University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06196957
- Sponsor's protocol ID
- REC/ 0346 samar
- Status last verified
- Jan 2024
- First submitted
- 22 Nov 2023
- Last updated
- 30 Jan 2024
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Publications
Cortopassi F, Gurung P, Pinto-Plata V. Chronic Obstructive Pulmonary Disease in Elderly Patients. Clin Geriatr Med. 2017 Nov;33(4):539-552. doi: 10.1016/j.cger.2017.06.006. Epub 2017 Aug 23.
PubMed 28991649Cowie RL, Conley DP, Underwood MF, Reader PG. A randomised controlled trial of the Buteyko technique as an adjunct to conventional management of asthma. Respir Med. 2008 May;102(5):726-32. doi: 10.1016/j.rmed.2007.12.012. Epub 2008 Jan 31.
PubMed 18249107Opat AJ, Cohen MM, Bailey MJ, Abramson MJ. A clinical trial of the Buteyko Breathing Technique in asthma as taught by a video. J Asthma. 2000;37(7):557-64. doi: 10.3109/02770900009090810.
PubMed 11059522
Study at a glance
From the registry record, last updated by the sponsor on 30 Jan 2024. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Effect of Senobi Breathing Exercise Versus Buteyko Breathing Technique on the Functional Performance Among Chronic Obstructive Pulmonary Disease Patient.
- ClinicalTrials.gov ID
- NCT06196957
- Acronym / sponsor ID
- REC/ 0346 samar
- Conditions
- Shortness of Breath
- Keywords
- Dyspnea, Quality of life, senobi,and buteyko
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 32 participants (actual)
- Lead sponsor
- Riphah International UniversityUniversity, hospital or other
- Study start
- 20 Jul 2023 (actual)
- Primary completion
- 1 Dec 2023 (actual)
- Study completion
- 10 Dec 2023 (actual)
- First posted
- 9 Jan 2024 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Effect of Senobi breathing exercise versus Buteyko breathing technique on functional performance among chronic obstructive pulmonary patient.
Detailed description
chronic obstructive pulmonary disease is a chronic inflammatory lung disease that cause obstructed airflow from the lungs. Symptoms include Breathing difficulty. cough, mucus production and wheezing. Its typically caused by long term exposure to irritating gasses or particulate matter, most often from cigarette smoker.
Emphysema and chronic bronchitis are two most common condition that contribute to chronic obstructive pulmonary disease. Chronic obstructive pulmonary disease is progressive disease that gets over a time. Clinical trials will be Conducted in Gulab Devi chest hospital in Lahore. Through the convenient sampling Technique. Which will be allocated through the random sampling two groups are involved group A and group B. In group A check the effect of Senobi techniques (stretch the body) and in group B check the effect of Buteyko technique. (Inhale the through the nose while mouth is closed) by using 6 mint walk test, Borg scale and quality of life questionnaire. Apply the technique to check the effectiveness of dyspnea and quality of life of patient The Buteyko technique offers a complementary method of reliving respiratory symptoms based on the voluntary control of breathing as well as considering the effect of environmental and dietary trigger. Data will be collected by the questionnaire and analyzed by using statistical package for the social science SPSS software version 21. The Buteyko method made its way to Australia to Europe and the unite states in 1990, it become best for the asthma and chronic obstructive pulmonary disease patient. The Senobi stretch exercise of the respiratory muscle improve the chest expansion and also improve the chest wall mobility in chronic obstructive pulmonary disease patient. Senobi breathing exercise was found to be effective for depression and it regulate the sympathetic nerve activity.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind (participant)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Buteyko technique | Experimental | Combination Product: pursed lip breathingGROUP A'(Buteyko technique) Participant in group A will be instructed to perform the Buteyko breathing exercise. Patient either on the sitting position or standing position. Patient will be relaxed the shoulder and rest lower back against the back of chair. Close the mouth while only breathing through nose. Breath into the diaphragm and chest should be still. Exhale slowly, then hold the breath. Use the index finger and thumb to plug the nose, Hold the breath until there is urge to breath Then inhale Repeat several times. With in 15 minutes. |
| Senobi technique | Active comparator | Combination Product: pursed lip breathingGROUP B (Senobi techniques) Senobi breathing exercise will be performed from standing, Arms will be extended firmly, The neck was extended so as face the ceiling. And the patient instructed to avoid over exertion Take a deep breath, hold for 3 second and then exhale through mouth. The time of exercise will be 15 minutes. |
Who may qualify
- Ages
- 40 to 80 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (5 listed)
- Age 40 -80
- COPD patient in stage 2 (GOLD criteria)
- Dyspnea (FEV1< 70 %)(26)
- Maximum expiratory pressure: 50%
- Smoker
Key exclusion criteria (5 listed)
- Patient with Tumor
- Patient with Cardiac Arrhythmias Patient
- Patient with cancer
- insulin dependent diabetes
- patient with thyroid disease
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| pursed lip breathingAlso: Senobi techniquepursed lip breathing | Combination product | Buteyko technique, Senobi technique |
Primary outcome
CASA Q (cough and sputum )
Time frame: 4 weeks
The cough and sputum assessment questionnaire (CASA-Q) was used to measure the severity and impact of cough and sputum in patients with COPD and chronic bronchitis. CASA-Q scores of each domain demonstrated significant association with HRQoL impairment CASA-Q was strongly lower when chronic bronchitis was present, but multivariate analyses demonstrated that the association of HRQoL impairment was greater with the cough impact domain score than with the usual definition of chronic bronchitis. The CASA-Q targets cough and sputum by an original approach assessing both the symptoms and impacts in dailyactivities within the last 7 days. Each item is answered ranging from never to always or from not at all to a lot / extremely as applicable each type is answered using five categories.
Dyspnea rating scale.
Time frame: 4 weeks
This scale is used for the measurement of the dyspnea ( shortness of breath ).This scale is questionnaire that consist of 5 breathlessness grade ,and the number 5 have maximum dyspnea
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 30 Jan 2024.
- Background: PubMed 28991649Cortopassi F, Gurung P, Pinto-Plata V. Chronic Obstructive Pulmonary Disease in Elderly Patients. Clin Geriatr Med. 2017 Nov;33(4):539-552. doi: 10.1016/j.cger.2017.06.006. Epub 2017 Aug 23.
- Background: PubMed 18249107Cowie RL, Conley DP, Underwood MF, Reader PG. A randomised controlled trial of the Buteyko technique as an adjunct to conventional management of asthma. Respir Med. 2008 May;102(5):726-32. doi: 10.1016/j.rmed.2007.12.012. Epub 2008 Jan 31.
- Background: PubMed 11059522Opat AJ, Cohen MM, Bailey MJ, Abramson MJ. A clinical trial of the Buteyko Breathing Technique in asthma as taught by a video. J Asthma. 2000;37(7):557-64. doi: 10.3109/02770900009090810.
- Individual participant dataSharing planned: No
Related trials for Shortness of Breath
Not yet recruiting
Mechanical Ventilator Adjustments and Patient Dyspnea
Respiratory Failure, Dyspnea During Mechanical Ventilation
RecruitingPhase 3
A Study to Learn About the Monthly Dosing Study Medicine Called Berobenatide in Adults With Breathing Problems During Sleep and Overweight or Obesity Who Do Not Use a Breathing Machine (PAP) (VESPER-OSA 2)
Apnea, Sleep Disorders
Not yet recruiting
Lung Cancer and Aging: Improving Well-being for Older Adults With Lung Cancer
Lung Cancer
RecruitingPhase 2
A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate-To-Severe Asthma
Asthma
Recruiting
The Impact of Telemedicine, Using the Caller's Mobile Phone Camera, on the Quality of Care Provided to Adult Patients Contacting the 15 Centre for Acute Dyspnea
Dyspnea
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Sumera abdulhameed, ms principal investigator
Riphah International University
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing pursed lip breathing in people with Shortness of Breath, run by Riphah International University at 1 site in Pakistan.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 5 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 30 Jan 2024. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Pakistan. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
CASA Q (cough and sputum ) (time frame: 4 weeks). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT06196957, which also lists 3 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 30 Jan 2024.